Baheal Pharmaceutical Gains Exclusive Rights to Roche's MabThera in China
CompanyDeals

Baheal Pharmaceutical Gains Exclusive Rights to Roche’s MabThera in China

Zhejiang Huahai's HB0034 Meets Primary Endpoint in GPP Study
CompanyDrug

Zhejiang Huahai’s HB0034 Meets Primary Endpoint in GPP Study

CStone Pharmaceuticals and SteinCares Ink Licensing Deal for PD-L1 Inhibitor in Latin America
CompanyDeals

CStone Pharmaceuticals and SteinCares Ink Licensing Deal for PD-L1 Inhibitor in Latin America

Fosun Pharma's 24-Valent Pneumococcal Vaccine Receives NMPA Approval for Phase I Trial
CompanyDrug

Fosun Pharma’s 24-Valent Pneumococcal Vaccine Receives NMPA Approval for Phase I Trial

Bio-Thera Solutions Inks Licensing Deal with World Medicine for BAT2206
CompanyDeals

Bio-Thera Solutions Inks Licensing Deal with World Medicine for BAT2206

Hainan Poly Pharm's US Partner Slate Run Pharmaceuticals Collaborates with Premier on Contrast Agents
CompanyDeals

Hainan Poly Pharm’s US Partner Slate Run Pharmaceuticals Collaborates with Premier on Contrast Agents

Gensaic and Novo Nordisk Team Up to Develop Cardiometabolic Therapies
CompanyDeals

Gensaic and Novo Nordisk Team Up to Develop Cardiometabolic Therapies

MSD China Reorganizes to Boost Mature Product Lines
Company

MSD China Reorganizes to Boost Mature Product Lines

Suzhou Abogen's RSV mRNA Vaccine IND Approved by China's CDE
CompanyDrug

Suzhou Abogen’s RSV mRNA Vaccine IND Approved by China’s CDE

CDE Launches SPARK Project to Boost Pediatric Antitumor Drug R&D
Policy / Regulatory

CDE Launches SPARK Project to Boost Pediatric Antitumor Drug R&D

BeiGene's Tevimbra Receives FDA Approval for ESCC Treatment
CompanyDrug

BeiGene’s Tevimbra Receives FDA Approval for ESCC Treatment

Organon's 2024 Financial Report Shows Steady Growth in Women's Health and Biosimilars
Company

Organon’s 2024 Financial Report Shows Steady Growth in Women’s Health and Biosimilars